Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Testing newborns

key information

source: Sickle Options

year: N/A

summary/abstract:

Sickle cell disease is a hereditary disease. Newborn screening or testing is done when the baby is between 24 hours and 7 days old. Your newborn baby will have a blood test before discharge from the hospital. Blood is obtained from the heel of your baby’s foot. 

Screening includes testing for about 40 disorders. Disorders screened for may vary according to different states. All 50 states and the District of Columbia require screening for congenital hypothyroidism, Galactosemia, Phenylketonuria and Sickle cell disease.

 

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close